Alice Blue Home
URL copied to clipboard

Trending News

Pharma stock jumps 7% after reporting 107% QoQ increase in net profits

Prominent pharma company posted ₹667.9 crore net profit in Q1 FY26, with revenue of ₹3,371.1 crore and total income of ₹3,507.6 crore, showing strong growth.

Introduction

Leading pharma company reported a net profit of ₹667.9 crore in Q1 FY26, up 107% QoQ and 21% YoY. Revenue reached ₹3,371.1 crore, growing 7% QoQ and 11% YoY, with total income at ₹3,507.6 crore.

Alice Blue Image

Also Read: Healthcare stock jumps 4% after company to acquire 76% stake in Pratiksha Hospital

Share price movement of Alkem Laboratories

On August 12, 2025, Alkem Laboratories Ltd opened at ₹4,851.45, up 0.19% from its previous close of ₹4,842.40. The stock reached a high of ₹5,205.45 (7.46%) and a low of ₹4,825.05. By 2:55 PM, it traded at ₹5,157.80, a 6.51% increase, with a market cap of ₹61,669.24 crore.

Alkem Laboratories Q1 FY26 Profit Surges 107%

Alkem Laboratories Limited reported a net profit of ₹667.9 crore for Q1 FY26, up 107.39% QoQ from ₹322.3 crore and a 21.38% increase YoY from ₹550.2 crore in Q1 FY25.

Revenue from operations rose to ₹3,371.1 crore in Q1 FY26, marking a 7.23% increase QoQ from ₹3,143.7 crore and an 11.21% growth YoY compared to ₹3,031.8 crore in Q1 FY25.

Total income reached ₹3,507.6 crore, up 6.62% QoQ from ₹3,289.7 crore and 11.30% higher YoY than ₹3,152.1 crore recorded in Q1 FY25.

Recent news on Alkem Laboratories

As of June 24, 2025, Alkem Laboratories Ltd sold its formulations manufacturing facility in Pithampur, Madhya Pradesh, to Rubicon Research for ₹149 crore.

Stock performance of Alkem Laboratories for Period of 1 week, 6 months, and 1 year

Alkem Laboratories Ltd delivered a -1.55% return over the past week, gained 2.65% in the past six months, and declined 15.2% over the past year.

Alice Blue Image

Also Read: Footwear stock jumps 14% after reporting 205.88% YoY increase in net profits

Shareholding pattern of Alkem Laboratories

ParticularsJun 2025Mar 2025Dec 2024
Promoter53.00%55.10%55.70%
FII9.10%9.40%10.10%
DII22%19%18.00%
Public16.10%16.10%16.20%

About Alkem Laboratories

Alkem Laboratories Ltd (NSE: ALKEM) is a leading pharmaceutical company in India with a 4.1% market share. It excels in anti-infectives and expanding in chronic therapies like neurology and cardiology.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs

Q: Why is Alkem Laboratories Ltd share price going up today?

A: The share price rose after the company reported a 107% QoQ increase in net profit for Q1 FY26.

Q: What does Alkem Laboratories Ltd specialize in?

A: It specializes in pharmaceutical and nutraceutical products, with strong presence in anti-infectives and chronic therapies.

Q: How much stake do promoters hold in Alkem Laboratories Ltd stock?

A: Promoters hold a 53.00% stake in Alkem Laboratories Ltd as per the latest data.

Submit the form, and get to know how you scored!!!

Gainers & Losers

Read More News
जैन: 6% अमेरिकी बॉन्ड यील्ड का भारतीय बाजार पर प्रभाव इक्विटी वैल्युएशन में गिरावट का जोखिम पैदा कर सकता है
Trending

जैन: 6% अमेरिकी बॉन्ड यील्ड का भारतीय बाजार पर प्रभाव इक्विटी वैल्युएशन में गिरावट का जोखिम पैदा कर सकता है

भारतीय बाजार पर अमेरिकी बॉन्ड यील्ड का प्रभाव: प्रशांत जैन ने 6% के स्तर पर वैश्विक मंदी और फंड निकासी

*T&C apply